| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Odonate Therapeutics Inc (NASDAQ: ODT)
ODT Technical Analysis
5
| As on 18th Mar 2022 ODT STOCK Price closed @ 1.29 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.72 & Strong Sell for SHORT-TERM with Stoploss of 15.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ODTSTOCK Price
| Open | 1.28 | Change | Price | % |
| High | 1.38 | 1 Day | 0.00 | 0.00 |
| Low | 1.28 | 1 Week | -0.07 | -5.15 |
| Close | 1.29 | 1 Month | -0.19 | -12.84 |
| Volume | 22257 | 1 Year | -13.37 | -91.20 |
| 52 Week High 27.39 | 52 Week Low 1.02 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.02 | -33.33% |
| GNLN | 0.01 | -50.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 141.97 | -2.09% |
| TSLA | 325.31 | 1.94% |
| LMDX | 0.02 | 0.00% |
| NCNA | 0.11 | -26.67% |
| USEG | 2.21 | 55.63% |
| AKTS | 0.04 | 0.00% |
| LCID | 2.10 | -2.78% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ODT Daily Charts |
ODT Intraday Charts |
Whats New @ Bazaartrend |
ODT Free Analysis |
|
|
ODT Important Levels Intraday
| RESISTANCE | 1.48 |
| RESISTANCE | 1.42 |
| RESISTANCE | 1.38 |
| RESISTANCE | 1.34 |
| SUPPORT | 1.24 |
| SUPPORT | 1.20 |
| SUPPORT | 1.16 |
| SUPPORT | 1.10 |
ODT Forecast June 2025
| 4th UP Forecast | 7.53 |
| 3rd UP Forecast | 5.53 |
| 2nd UP Forecast | 4.29 |
| 1st UP Forecast | 3.06 |
| 1st DOWN Forecast | -0.48 |
| 2nd DOWN Forecast | -1.71 |
| 3rd DOWN Forecast | -2.95 |
| 4th DOWN Forecast | -4.95 |
ODT Weekly Forecast
| 4th UP Forecast | 5.65 |
| 3rd UP Forecast | 4.25 |
| 2nd UP Forecast | 3.39 |
| 1st UP Forecast | 2.52 |
| 1st DOWN Forecast | 0.06 |
| 2nd DOWN Forecast | -0.81 |
| 3rd DOWN Forecast | -1.67 |
| 4th DOWN Forecast | -3.07 |
ODT Forecast2025
| 4th UP Forecast | 54.4 |
| 3rd UP Forecast | 37.37 |
| 2nd UP Forecast | 26.84 |
| 1st UP Forecast | 16.31 |
| 1st DOWN Forecast | -13.73 |
| 2nd DOWN Forecast | -24.26 |
| 3rd DOWN Forecast | -34.79 |
| 4th DOWN Forecast | -51.82 |
Odonate Therapeutics Inc ( NASDAQ USA Symbol : ODT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ODT Business Profile
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York. Address: 3 East 28th Street, New York, NY, United States, 10016
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service